Hecht, Markus 
; Gostian, Antoniu Oreste ; Eckstein, Markus ; Rutzner, Sandra ; von der Grün, Jens ; Illmer, Thomas ; Hautmann, Matthias G. ; Klautke, Gunther ; Laban, Simon ; Brunner, Thomas ; Hinke, Axel ; Becker, Ina ; Frey, Benjamin ; Semrau, Sabine ; Geppert, Carol I. ; Hartmann, Arndt ; Balermpas, Panagiotis ; Budach, Wilfried ; Gaipl, Udo S. ; Iro, Heinrich ; Fietkau, Rainer
; Gostian, Antoniu Oreste ; Eckstein, Markus ; Rutzner, Sandra ; von der Grün, Jens ; Illmer, Thomas ; Hautmann, Matthias G. ; Klautke, Gunther ; Laban, Simon ; Brunner, Thomas ; Hinke, Axel ; Becker, Ina ; Frey, Benjamin ; Semrau, Sabine ; Geppert, Carol I. ; Hartmann, Arndt ; Balermpas, Panagiotis ; Budach, Wilfried ; Gaipl, Udo S. ; Iro, Heinrich ; Fietkau, Rainer Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8
Article
Hecht, Markus, Gostian, Antoniu Oreste, Eckstein, Markus, Rutzner, Sandra , von der Grün, Jens, Illmer, Thomas, Hautmann, Matthias G., Klautke, Gunther, Laban, Simon , Brunner, Thomas, Hinke, Axel, Becker, Ina, Frey, Benjamin, Semrau, Sabine, Geppert, Carol I., Hartmann, Arndt, Balermpas, Panagiotis , Budach, Wilfried, Gaipl, Udo S., Iro, Heinrich and Fietkau, Rainer
(2020)
Safety and efficacy of single cycle induction treatment with cisplatin/docetaxel/ durvalumab/tremelimumab in locally advanced HNSCC: first results of CheckRad-CD8.
Journal for ImmunoTherapy of Cancer 8 (2), e001378.
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Journal for ImmunoTherapy of Cancer | ||||
| Publisher | BMJ PUBLISHING GROUP | ||||
| Place of Publication | LONDON | ||||
| Volume | 8 | ||||
| Number of Issue or Book Chapter | 2 | ||||
| Page Range | e001378 | ||||
| Date | 2020 | ||||
| Date of publication | 11 Oct 2021 13:05 | ||||
| Institutions | Medicine > Lehrstuhl für Strahlentherapie | ||||
| Identification Number |
| ||||
| Keywords | SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; ADVANCED HEAD; OROPHARYNX CANCER; OPEN-LABEL; PHASE-III; CHEMOTHERAPY; CISPLATIN; FLUOROURACIL; DOCETAXEL; radioimmunotherapy; head and neck neoplasms; CD8-Positive T-lymphocytes; clinical trials; Phase II as topic; combined modality therapy | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 50455 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric